Advertisement
News
Subscribe to MDT Magazine News

Two New U.S. Patents Issued to Dyadic International

April 7, 2011 7:36 am | by Bio-Medicine.Org | Comments

JUPITER, Fla., April 7, 2011 /- Dyadic International, Inc. ("Dyadic") (OTC Pink: DYAI), a global biotechnology company focused on the discovery, development, manufacture and sale of enzyme and protein products for the bioenergy, industrial enzyme and biopharmaceutical industries,...

TOPICS:

C3i Opens Asia Language Center in Dalian, China

April 7, 2011 7:36 am | by Bio-Medicine.Org | Comments

MORRISTOWN, N.J., April 7, 2011 /- C3i, the global leader in technology support and BPO services for the pharmaceutical industry and Oracle Gold Partner, announced today the opening of its new Global Operations Center in China. The operations center, located in the northern city of...

TOPICS:

Arkansas Department of Health Chooses AT & T to Streamline Delivery of Public Health Programs

April 7, 2011 7:36 am | by Bio-Medicine.Org | Comments

LITTLE ROCK, Ark., April 7, 2011 /- AT&T * today announced that the Arkansas Department of Health has deployed TotalMobile from AT&T to design a mobile flu clinic solution to help the agency more efficiently transmit flu vaccination records across the state. The Department plans...

TOPICS:
Advertisement

PixelOptics Closes $45 Million Financing

April 7, 2011 7:36 am | by Bio-Medicine.Org | Comments

ROANOKE, Va., April 7, 2011 /- PixelOptics ("Pixel"), the world's first electronic focusing eyeglass company, announced today the successful closing of a $45M financing lead by Safeguard Scientifics, Inc. (NYSE: SFE).  The financing is comprised of $35M equity investment and $10M...

TOPICS:

Adeona to Raise $3.5 Million in Registered Direct Offering

April 7, 2011 7:35 am | by Bio-Medicine.Org | Comments

ANN ARBOR, Mich., April 7, 2011 /- Adeona Pharmaceuticals, Inc. (AMEX: AEN ), a developer of innovative medicines for serious central nervous system diseases, announced today that it has executed an agreement for the sale of 1,688,782 shares of its common stock at approximately $2.0725...

TOPICS:

China Sky One Medical Obtains Production Licenses for Thirteen New Medical Products

April 7, 2011 7:34 am | by Bio-Medicine.Org | Comments

HARBIN, China, April 7, 2011 /PRNewswire-Asia-FirstCall/ -- China Sky One Medical, Inc. ("China Sky One Medical" or "the Company") (NASDAQ: CSKI ), a leading fully integrated pharmaceutical company in the People's Republic of China ("PRC"), today announced that the Company, jointly with...

TOPICS:

Benzocaine Topical Products: Sprays, Gels and Liquids: Risk of Methemoglobinemia

April 7, 2011 6:30 am | by U.S. Food & Drug Administration | Comments

FDA continues to receive reports of methemoglobinemia, a serious and potentially fatal adverse effect, associated with benzocaine products.

TOPICS:

TSMC disclose plans expansion in ?Mid-end? IC-packaging

April 7, 2011 5:37 am | by I-Micronews | Comments

During the TSMC 2011 Technology Symposium on Tuesday (April 5), Taiwan Semiconductor Manufacturing Co. Ltd. (TSMC) disclosed plans to expand its IC-packaging efforts reported EETimes.

Advertisement

Vystar® Corporation Appoints Joanne Kearney as Vice President of Marketing

April 7, 2011 5:36 am | by Bio-Medicine.Org | Comments

ATLANTA, April 7, 2011 /- Vystar® Corporation (OTCBB:VYST), the creator of Vytex® Natural Rubber Latex (NRL), a patented, all-natural raw latex material that significantly reduces antigenic proteins and other non-rubbers found in natural rubber latex, has appointed Joanne...

TOPICS:

Graymark Resupply Orders Reach Record Levels in Q1 2011, Up 107% Year-Over-Year

April 7, 2011 5:36 am | by Bio-Medicine.Org | Comments

OKLAHOMA CITY, April 7, 2011 /- Graymark Healthcare Inc. (NASDAQ: GRMH ), the nation's second largest provider of diagnostic sleep services and an innovator in comprehensive care for obstructive sleep apnea (OSA), realized a 107% year-over-year increase in patient resupply shipments in...

TOPICS:

FDA Approves Horizant To Treat Restless Legs Syndrome

April 7, 2011 5:35 am | by Bio-Medicine.Org | Comments

SILVER SPRING, Md., April 7, 2011 /PRNewswire-USNewswire/ -- On April 6, the U.S. Food and Drug Administration approved Horizant Extended Release Tablets (gabapentin enacarbil), a once-daily treatment for moderate-to-severe restless legs syndrome (RLS). (Logo:...

TOPICS:

Marinus Pharmaceuticals Issued Patent for Ganaxolone

April 7, 2011 5:35 am | by Bio-Medicine.Org | Comments

NEW HAVEN, Conn., April 7, 2011 /- Marinus Pharmaceuticals, Inc., the leader in development of neurosteroids for central nervous system disorders, today announced that the United States Patent and Trademark Office (USPTO) issued the company Patent Number 7,858,609 entitled, "Solid...

TOPICS:

Shionogi Announces Commercial Availability of CUVPOSAâ„¢ (Glycopyrrolate) Oral Solution for Pediatric Chronic Severe Drooling Associated With Neurologic Conditions

April 7, 2011 5:34 am | by Bio-Medicine.Org | Comments

FLORHAM PARK, N.J., April 7, 2011 /- Shionogi Inc., the U.S.-based group company of Shionogi & Co., Ltd., today announced the U.S. commercial availability of CUVPOSA™ (glycopyrrolate) oral solution, the first and only FDA-approved treatment to reduce chronic severe drooling in...

TOPICS:

NewCardio Study Shows my3KG Improves Diagnostic Accuracy in Diabetics With Acute Myocardial Infarction

April 7, 2011 5:33 am | by Bio-Medicine.Org | Comments

SANTA CLARA, Calif., April 7, 2011 /- PR Newswire – NewCardio, Inc., (OTC BB: NWCI) a cardiac diagnostic technology provider, announced today that the Company has been invited by the American Diabetes Association (ADA) to present the results of a key study showing that NewCardio's...

TOPICS:

Cardinal Health to Release Third Quarter Results on April 28

April 7, 2011 4:37 am | by Bio-Medicine.Org | Comments

DUBLIN, Ohio, April 7, 2011 /- Cardinal Health plans to release third-quarter financial results for its fiscal 2011 on Thursday, April 28, prior to the opening of trading on the New York Stock Exchange. The company has scheduled a webcast and conference call for April 28 at 8:30 a.m. EDT...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading